
	Where results make sense

Topic: AstraZeneca

Related Topics

AstraZeneca plc

Lists of companies

List of European companies

Imperial Chemical Industries

Ingate

Telia Sonera

Arla Foods

Lundbeck

Securitas AB

Pharmaceutical company

Shire Pharmaceuticals

Investor AB

Drug companies

Bure Equity

Autoliv

	AstraZeneca Group News
		AstraZeneca PLC said Monday that it has received approval from the U.S. Food and Drug Administration for a new formulation of its popular Seroquel schizophrenia treatment, making it the first medicine to treat...
		LONDON AstraZeneca said Thursday that it had stopped development of an experimental stroke medicine, and third-quarter sales for three of its top five drugs were lower than analysts estimated.
		Drug stocks were mixed in afternoon trading Thursday as shares of AstraZeneca fell on news that because of disappointing Phase III clinical-trial results, it was pulling the plug on an experimental drug to...
	www.topix.net /com/azn (733 words)

	AstraZeneca Decides to Withdraw Exanta™
		AstraZeneca estimates that approximately 400 patients are currently being prescribed the drug for short-term prevention of venous thromboembolism (VTE) following orthopaedic surgery (OS).
		AstraZeneca has informed regulatory authorities of its decision to withdraw Exanta and is now communicating with all prescribers and healthcare professionals to advise them that no new patients should be started on Exanta.
		AstraZeneca will maintain the supply of Exanta for a short period to allow doctors to manage patients during this transition.
	www.astrazeneca.fi /pressrelease/10674.aspx (516 words)

	AstraZeneca - www.astrazeneca.ch
		AstraZeneca will provide an update on its strategy and development pipeline through to the end of the decade at a business review meeting to be held in London today.
		AstraZeneca’s leading genomic approach to anti-bacterials is yielding its first candidates.
		Changes in AstraZeneca’s research approach to cancer therapy and to “personalised medicine” are paying dividends, delivering a range of targeted agents into development.
	www.astrazeneca.ch /index/ta-read.htm?id=18668 (1891 words)

	AstraZeneca Jobs - Employment Opportunities at Monster.com
		AstraZeneca is among the leading research organizations in the industry and is a leader in applying biotechnology.
		AstraZeneca is a leader in community affairs, and on the national level, is in the forefront of efforts to improve the lives of the underprivileged and those whose health needs are underserved.
		AstraZeneca offers competitive compensation and benefits, a commitment to development, and the opportunity to be a part of an exciting, dynamic environment.
	company.monster.com /astrazeneca (302 words)

	AstraZeneca - www.astrazeneca.ch
		AstraZeneca announced today that the U.S. Food and Drug Administration (FDA) has approved additional efficacy labelling information, based on 12-week data for SEROQUEL (quetiapine), a psychotropic medication indicated for the treatment of acute manic episodes associated with bipolar I disorder.
		AstraZeneca today also announced important new data showing that SEROQUEL may be an effective option for the treatment of agitation associated with dementia, including Alzheimer’s disease, in the elderly patient population.
		AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index.
	www.astrazeneca.ch /fr/index/ta-read.htm?id=16930 (1311 words)

	AstraZeneca Young Minds
		The APA and AstraZeneca reserve the right to use the researcher's name and institution name for public relations purposes.
		AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services.
		In NS, AstraZeneca is dedicated to providing medicines, which have the potential to change patients' lives.
	youngminds.astrazeneca.com (228 words)

	AstraZeneca - Wikipedia, the free encyclopedia
		Despite Astrazeneca's gross reported earnings of over $18.8 Billion during 2003, the company performed mass layoffs for employees based within the United States in order to outsource various departments to contracting firms within India and China.
		In June of 2003, AstraZeneca pleaded guilty to a felony charge of health care fraud and agreed to pay $355 million to settle criminal and civil accusations that it engaged in a nationwide scheme to illegally market a prostate cancer drug.
		Current members of the board of directors of AstraZeneca are: Peter Bonfield, David Brennan, John Buchanan, Jane E. Henney, Michele Hooper, Joe Jimenez, Tom McKillop, Håkan Mogren, Erna Möller, Bridget Ogilvie, John Patterson, Louis Schweitzer, Jonathan Symonds, and Marcus Wallenberg.
	en.wikipedia.org /wiki/AstraZeneca (798 words)

	ShareCast - News you can use
		AstraZeneca lifted its full year earnings guidance today however the news was overshadowed by disappointing results from a trial into its stroke drug.
		Drug giant AstraZeneca was on the move ahead of its third quarter results later this week after it published positive news regarding its bipolar drug Seroquel.
		AstraZeneca kept its earnings guidance unchanged for the year, disappointing investors who had hoped the drug giant would raise the bar yet again.
	www.sharecast.com /cgi-bin/sharecast/security.cgi?csi=10009 (380 words)

	Boston, MA (Site not responding. Last check: 2007-10-13)
		AstraZeneca RandD Boston is one of the newest additions to our global scientific community.
		AstraZeneca RandD Boston continues to add dynamic new resources to its global research efforts in the battle against cancer, a disease that is the second leading cause of death in the United States.
		These capabilities are supported by a strong network of external collaborations designed to enhance our current capabilities, to evaluate new ones, and to provide drug discovery scientists with access to state of the art tools and information.
	www.astrazeneca-boston.com (676 words)

	Södertälje
		AstraZeneca RandD Södertälje runs a research and development centre mainly within the fields of therapy for; the Central Nervous System (CNS) and Pain Control.
		This is proof indeed that the area of CNS is one of the most difficult areas as concerns medical research.
		AstraZeneca RandD Södertälje is a part of AstraZeneca's organisation in Södertälje.
	www.astrazeneca.se /OmOss/Sdertlje-628174.aspx?l1=5&l2=6&l3=1&l4=3&pid=16173 (237 words)

	AstraZeneca Pledges More Than $1 Million in Contributions and Medicine to Victims of Hurricane Katrina
		AstraZeneca is committed, along with the broader healthcare community, to helping people affected by this terrible event, some of whom include our own AstraZeneca employees," said David Brennan, President and CEO, AstraZeneca US.
		Those who previously have been prescribed an AstraZeneca medication but who are not enrolled in an AstraZeneca Patient Assistance Program are urged to visit a physician, pharmacist, local clinic/hospital or disaster relief agency to receive the AstraZeneca product that they have been prescribed.
		AstraZeneca is working with the American Red Cross and other agencies to continually monitor the impact on affected areas and to provide additional product as needed.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-01-2005/0004098510&EDATE= (381 words)

	AstraZeneca in the United States (via CobWeb/3.1 planetlab2.cs.virginia.edu) (Site not responding. Last check: 2007-10-13)
		This traveling interactive exhibit gives participants and guests at various events throughout the country education and information about breast cancer diagnosis and treatment.
		For more than three decades, AstraZeneca has helped lead the way in oncology and breast cancer-related research and development.
		The CEO Cancer Gold Standard is a rigorous, culture-changing initiative of the CEO Roundtable on Cancer through which companies promote cancer prevention, early detection, and access to quality care for all U.S. employees and their families.
	www.astrazeneca-us.com.cob-web.org:8888 (173 words)

	BBC NEWS \| Business \| AstraZeneca faces EU patent fine
		Drugmaker AstraZeneca has been fined £40m (60m euros) for illegally trying to prevent generic competition to its best-selling ulcer drug Losec.
		AstraZeneca said it would appeal against the decision which it claimed was "legally and factually flawed".
		AstraZeneca said it had acted in good faith when it sought to extend the patent and would appeal against the verdict in the EU's Court of Justice.
	news.bbc.co.uk /1/low/business/4096216.stm (311 words)

	AstraZeneca Norge
		AstraZeneca er et av verdens ledende farmasøytiske selskaper.
		AstraZeneca utvikler og markedsfører kostnadseffektive behandlingsløsninger basert på innovative legemidler for å gi mennesker en bedre hverdag.
		AstraZeneca søker å komme i kontakt med leger som har interesse for utprøving av nye medisiner og som kan tenke seg å delta som studielege i en eller flere av våre kliniske studier.
	www.astrazeneca.no (228 words)

	S t u d e n t w e b b e n - AstraZenecas webbplats för dig som studerar
		Här får du bland annat veta hur det är att arbeta på AstraZeneca och få en inblick i vilka möjligheter och utmaningar som finns inom företaget.
		AstraZeneca kommer finnas på plats under arbetsmarknadsdagarna 14-15 november, och kommer även synas i andra arrangemang under Armadadagarna.
		Bland de 126 arbetsgivare som undersökts i denna undersökning är AstraZeneca den 7:e attraktivaste arbetsgivaren bland högskolestudenterna och den 4:e attraktivaste bland de unga yrkesverksamma teknologerna.
	www.studentwebben.nu (203 words)

	RedOrbit - Health - Schering and AstraZeneca to Develop Breast Cancer Drug (Site not responding. Last check: 2007-10-13)
		German drug maker Schering AG has revealed plans to work with AstraZeneca to co-develop and jointly commercialize a new breast cancer treatment.
		The companies are collaborating to develop and commercialize Schering's novel selective estrogen receptor downregulator (SERD,) for the treatment of breast cancer.
		AstraZeneca - which is looking to rebuild its pipeline following recent high-profile setbacks of its diabetes drug and lung cancer trials - will lead the clinical development, while Schering will lead the non-clinical and process development along with manufacturing.
	www.redorbit.com /news/health/658200/schering_and_astrazeneca_to_develop_breast_cancer_drug/index.html?source=r_health' (283 words)

	Targacept and AstraZeneca Announce Global License and Research Collaboration Agreement (Site not responding. Last check: 2007-10-13)
		While the parties will collaborate to identify novel candidate drugs, AstraZeneca will be primarily responsible for and will fund the development and commercialization of TC-1734 and any compounds that arise out of the four- year research collaboration.
		About AstraZeneca AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services.
		The AstraZeneca neuroscience pipeline includes leading approaches for the treatment of depression and anxiety, overactive bladder, dementia, stroke, pain control and anaesthesia.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-28-2005/0004239937&EDATE= (746 words)

	Gastrointestinal Products - acid reflux treatment, ulcers, peptic ulcer, dyspepsia - AstraZeneca Australia
		AstraZeneca has pioneered research and committed to advancing the treatment of acid related diseases.
		AstraZeneca's development of the first proton pump inhibitor (PPI) class began in 1974 which ultimately lead to it becoming the world leader in the treatment of acid-related diseases.
		AstraZeneca also has an active research programme in this area.
	www.astrazeneca.com.au /article/502012.aspx (590 words)

	AstraZeneca - SourceWatch
		AstraZeneca is one of the world's largest pharmaceutical companies.
		The company has accused animal rights activists of forcing its research operations to Asia and South America [1].
		AstraZeneca is also the creator of National Breast Cancer Awareness Month.
	www.sourcewatch.org /index.php?title=AstraZeneca (203 words)

	AstraZeneca Clinical Trials - Information on AstraZeneca-sponsored clinical trials (via CobWeb/3.1 ... (Site not responding. Last check: 2007-10-13)
		AstraZeneca conducts clinical trials to help determine the safety and efficacy of a new medicine.
		In line with our Group Corporate Responsibility Policy on transparency, we are committed to open communication of information on AstraZeneca’s clinical trials.
		Results will be published whether or not they are favourable to AstraZeneca.
	www.astrazenecaclinicaltrials.com.cob-web.org:8888 (221 words)

	PGATOUR.com - AstraZeneca Charity Challenge (Site not responding. Last check: 2007-10-13)
		Troy Matteson is this week's AstraZeneca Charity Challenge winner for his standing as the 54-hole co-leaders at the FUNAI Classic at WALT DISNEY WORLD Resort.
		In 2006, AstraZeneca will donate $3.5 million to charitable organizations as part of the renamed AstraZeneca Charity Challenge -- a season-long competition that rewards the tournament leader entering the final round.
		Since the program's inception in 2004, AstraZeneca (previously through the CRESTOR ®; Charity Challenge) has donated $6.2 million to charity and will reach $9.7 million in giving at the conclusion of the 2006 season.
	astrazeneca.pgatour.com (216 words)

	CRESTOR® - Rosuvastatin (via CobWeb/3.1 planetlab2.cs.virginia.edu) (Site not responding. Last check: 2007-10-13)
		They are usually mild and tend to go away.
		CRESTOR was licensed by AstraZeneca from Shionogi and Co LTD, Osaka, Japan.
		CRESTOR is a registered trademark of the AstraZeneca group of companies.
	www.crestor.com.cob-web.org:8888 (239 words)

	AstraZeneca drug gets extended use license from European authorities \| newratings.com (Site not responding. Last check: 2007-10-13)
		AstraZeneca quote - chart - all headlines - investor relations - analyst actions - add to watchlist - current ratings
		LONDON, July 12 (newratings.com) — European health regulatory authorities have granted an extended marketing license to AstraZeneca Plc’s (AZN.ISE) Arimidex for the treatment of breast cancer patients.
		The regulators said Arimidex can now be given to post-menopausal women following breast cancer surgery who have been taking tamoxifen for two to three years.
	www.newratings.com /analyst_news/article_1316900.html (306 words)

	AstraZeneca Cardiovascular - leading innovation in cardiovascular medicine
		AstraZeneca Cardiovascular - leading innovation in cardiovascular medicine
		AstraZeneca’s mission in the cardiovascular therapy area is to increase lifespan and improve quality of life by reducing the risk, prevalence, and impact of cardiovascular and metabolic disease.
		This site is intended for an international audience of healthcare professionals, providing information on our heritage, our products and our research and development programmes.
	www.astrazenecacardiovascular.com (101 words)

	AstraZeneca Sverige - läkemedelsbolag, receptbelagda läkemedel, medicinsk forskning
		AstraZeneca Sverige - läkemedelsbolag, receptbelagda läkemedel, medicinsk forskning
		2006-10-26 : AstraZeneca tillkännager resultat från SAINT II-studien - NXY-059 visar ingen effekt vid akut ischemisk stroke
		Astrazeneca: Humira effektivt mot Crohn enligt fas III-studie
	www.astrazeneca.se (80 words)

	Datamonitor - PharmaVitae 2002: AstraZeneca - Company Analysis Report
		This analysis examines the current position and future outlook for AstraZeneca in the ethical pharmaceutical sector.
		It encompasses company strategy, comparative portfolio and pipeline analysis and assessment of financial performance, providing 1, 3 and 6 year sales forecasts for key drugs.
		Determine whether AstraZeneca's current reliance on in-house RandD for growth will push it closer to a merger with another large player
	www.datamonitor.com /~42078864316f452c8eab7bdc3db5bc35~/industries/research/?pid=CSHC0965 (176 words)

Try your search on: Qwika (all wikis)